EQT Life Sciences Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Professionals
-
24
- Investments
-
239
- Portfolio
-
6
- Exits
-
132
EQT Life Sciences General Information
Company Description
Founded in 1988, EQT Life Sciences was a venture capital firm based in Amsterdam, Netherlands. The firm preferred to invest in companies operating in healthcare, life sciences, oncology, the internet of things, and health technology sectors across the United States and Europe. The firm was acquired by EQT on 28th February 2022.
Business Details
Website
www.lspvc.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- Johannes Vermeerplein 9
- 1071 DV Amsterdam
- Netherlands
EQT Life Sciences Investments (239)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Avidicure | 24-Apr-2025 | Seed Round | Drug Discovery | Pre-Clinical Trials | ||
| Atalanta Therapeutics | 28-Jan-2025 | Drug Discovery | Pre-Clinical Trials | |||
| XyloCor Therapeutics | 07-Jan-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Noema Pharma | 11-Dec-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Evommune | 30-Oct-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| atbtherapeutics | 01-Oct-2024 | Drug Discovery | Generating Revenue | |||
| Pantera (Drug Discovery) | 11-Sep-2024 | Drug Discovery | Generating Revenue | |||
| Shinobi Therapeutics | 01-Aug-2024 | Biotechnology | Pre-Clinical Trials | |||
| Asceneuron | 16-Jul-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Vico Therapeutics | 24-Jun-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
EQT Life Sciences Exits (132)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Nobi (Home Furnishings) | 28-Jan-2025 | Later Stage VC | |
| Syntaxin | 18-Dec-2024 | ||
| Visus Therapeutics | 12-Dec-2024 | ||
| AviadoBio | 08-Oct-2024 | ||
| Lumeon | 02-Aug-2024 | ||
| Endotronix | 24-Jul-2024 | ||
| Amolyt Pharma | 15-Jul-2024 | ||
| ImCyse | 20-Jun-2024 | ||
| Nkarta Therapeutics | 26-Mar-2024 | Public Investment 2nd Offering | |
| Cardior | 25-Mar-2024 | Merger/Acquisition |
EQT Life Sciences Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
EQT Life Sciences Co-Investors (277)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Andera Partners | 8 |
|
|
||
| Kurma Partners |
|
|
|||
| Sofinnova Partners |
|
|
|||
| Johnson & Johnson Innovation - JJDC |
|
|
|||
| Polaris Partners |
|
|
EQT Life Sciences FAQs
-
What is EQT Life Sciences?
Founded in 1988, EQT Life Sciences was a venture capital firm based in Amsterdam, Netherlands.
-
When was EQT Life Sciences founded?
EQT Life Sciences was founded in 1998.
-
Where is EQT Life Sciences headquartered?
EQT Life Sciences is headquartered in Amsterdam, Netherlands.
-
What is EQT Life Sciences's total asset value?
EQT Life Sciences has around in total assets under management.
-
How many investments has EQT Life Sciences made?
EQT Life Sciences has made 239 investments.
-
What has EQT Life Sciences invested in?
EQT Life Sciences has made numerous investments in companies like Avidicure, Atalanta Therapeutics, and XyloCor Therapeutics within the Drug Discovery industry.
-
What has EQT Life Sciences invested in recently?
EQT Life Sciences's latest investment was on 24-Apr-2025 in Avidicure, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
